Log In
BCIQ
Print this Print this
 

KA2237

  Manage Alerts
Collapse Summary General Information
Company Karus Therapeutics Ltd.
DescriptionPhosphoinositide 3-kinase (PI3K) catalytic subunit beta polypeptide (PI3KCB; p110beta) and PI3KCD inhibitor
Molecular Target Phosphoinositide 3-kinase (PI3K) catalytic subunit beta polypeptide (PI3KCB) (p110beta) ; Phosphoinositide 3-kinase (PI3K) catalytic subunit delta polypeptide (PI3KCD) (p110delta)
Mechanism of ActionPhosphoinositide 3-kinase (PI3K) delta inhibitor; Phosphoinositide 3-kinase (PI3K) beta inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

12/10/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today